Kendra Adams
Insider Reports History
- Location
- Watertown, MA
- Signature
- /s/ Shagha Russell, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Kendra Adams:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | Chief Financial Officer | Common Stock | 385,098 | $727,835 | $1.89 | 14 Feb 2026 | Direct |
| C4 Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 130,600 | 14 Feb 2025 | Direct |
Insider Reports Filed by Kendra Adams
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | 13 Feb 2026 | 5 | -$32,591 | 4 | Chief Financial Officer | 18 Feb 2026, 17:04 |
| CCCC | C4 Therapeutics, Inc. | 18 Sep 2025 | 2 | -$9,213 | 4 | Chief Financial Officer | 19 Sep 2025, 16:13 |
| CCCC | C4 Therapeutics, Inc. | 13 Feb 2025 | 4 | -$20,459 | 4 | Chief Financial Officer | 18 Feb 2025, 16:54 |
| CCCC | C4 Therapeutics, Inc. | 07 Nov 2024 | 3 | -$6,656 | 4 | Chief Financial Officer | 12 Nov 2024, 16:17 |
| CCCC | C4 Therapeutics, Inc. | 18 Sep 2024 | 1 | -$11,720 | 4 | Chief Financial Officer | 20 Sep 2024, 16:13 |
| CCCC | C4 Therapeutics, Inc. | 16 Sep 2024 | 3 | -$4,204 | 4 | Chief Financial Officer | 17 Sep 2024, 17:12 |
| CCCC | C4 Therapeutics, Inc. | 07 Mar 2024 | 2 | $0 | 4 | Chief Financial Officer | 08 Mar 2024, 19:21 |
| CCCC | C4 Therapeutics, Inc. | 13 Feb 2024 | 3 | -$8,496 | 4 | Chief Financial Officer | 15 Feb 2024, 17:02 |
| CCCC | C4 Therapeutics, Inc. | 18 Sep 2023 | 2 | $0 | 4 | Chief Financial Officer | 19 Sep 2023, 19:21 |
| CCCC | C4 Therapeutics, Inc. | 18 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 19 Sep 2023, 19:20 |